How many insider declarations has Medline, Michael Bennett filed?

Medline, Michael Bennett has filed 4 public insider declarations with SEDI.

What is Medline, Michael Bennett's role?

Medline, Michael Bennett's reported role is not specified by the regulator across the filings.

Which companies does Medline, Michael Bennett report trades for?

Medline, Michael Bennett reports trades for 2 companies, including Thomson Reuters Corporation.

What is Medline, Michael Bennett's declared buy vs sell volume?

Across the available history, declared buys total 8k€ and disposals 0.

← Executives ★ Sign in to follow

MM

Medline, Michael Bennett

OWNER 10PCT

·SEDI

Thomson Reuters Corporation Bank of Nova Scotia, The

Cumul. flow

0

Total declarations

0

Companies

€8,047

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the detailed record of transactions filed by Medline, Michael Bennett. Officer active across 2 companies, notably Thomson Reuters Corporation. In total, 4 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €8k. History available since 15 June 2026. The latest transaction was disclosed on 29 July 2026 (30 - Acquisition or disposition under a purchase/ownership plan). Regulator: SEDI. The full history is free.

Companies and markets linked to Medline, Michael Bennett

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Thomson Reuters Corporation (CA)Bank of Nova Scotia, The (CA)

Declarations4 total

▲

Medline, Michael Bennett

4 - Director of IssuerExecutives29 Jul 2026Bank of Nova Scotia, The

CA$12,9620SEDI ↗

107 shares@ CA$121.14Rights Director Deferred Stock Units (DDSU)TSXSEDI:4757139

Canonical exit: 27 Oct 2026 (T+90)

●

Medline, Michael Bennett

4 - Director of IssuerExecutives29 Jul 2026Bank of Nova Scotia, The

CA$86,2520SEDI ↗

712 shares@ CA$121.14Rights Director Deferred Stock Units (DDSU)TSXSEDI:4757136

●

Medline, Michael Bennett

6 - Director or Senior Officer of 10% Security HolderExecutives15 Jun 2026Thomson Reuters Corporation

CA$8,46724SEDI ↗

104 shares@ CA$81.410.0000% mcap100.0% of flowDeferred Share UnitsTSXSEDI:4737178

●

Medline, Michael Bennett

6 - Director or Senior Officer of 10% Security HolderExecutives5 Jan 2026Thomson Reuters Corporation

11SEDI ↗

Deferred Share UnitsTSXSEDI:4737177

4 of 4 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

MM

Medline, Michael Bennett

OWNER 10PCT

·SEDI

Thomson Reuters Corporation Bank of Nova Scotia, The

Cumul. flow

0

Total declarations

0

Companies

€8,047

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the detailed record of transactions filed by Medline, Michael Bennett. Officer active across 2 companies, notably Thomson Reuters Corporation. In total, 4 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €8k. History available since 15 June 2026. The latest transaction was disclosed on 29 July 2026 (30 - Acquisition or disposition under a purchase/ownership plan). Regulator: SEDI. The full history is free.